Transfer Membrane Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 1.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Transfer Membrane Market Analysis
The Transfer Membrane Market is expected to register a CAGR of 1.5% over the forecast period.
The emergence of new and evolving SARS-CoV-2 variants fueled the need for change in the form of innovative and more adaptable diagnostic approaches for SARS-CoV-2 infection detection. On the other hand, due to new variations and variable symptoms across infected persons, creating rapid and sensitive testing tools became difficult. According to the data from the Journal Annals of Medicines published in February 2022, novel vaccines and medicines were continually being explored to elicit an immune response capable of effectively targeting SARS-CoV-2 and its variations. Such studies indicated the need for new therapeutics for targeting diseases. Therefore, it was observed that the pandemic had a significant impact on the market studied. However, currently, the market has reached a pre-pandemic nature and is expected to witness strong growth in the coming years.
The market is primarily driven by the increasing investment in R&D by pharmaceutical and biopharmaceutical companies and the development of new therapeutics for targeting chronic diseases. According to the European Commission Industrial R&D Investment prediction, data updated in December 2021, the United States planned to spend more than USD 679 billion on research and development in 2022. It was anticipated that China would spend roughly USD 551.1 billion on R&D in 2022. Hence, the high investment in R&D is believed to propel market growth as R&D opens doors for diagnostic research.
Furthermore, the growing prevalence of autoimmune diseases and infectious diseases and the increasing focus on the development of novel drug therapies based on DNA and RNA are projected to boost market growth over the forecast period. As per the data from CDC and National Lupus Registries published in April 2021, an estimate of the number of systemic lupus erythematosus cases in the United States was 72.8 per 100,000 person-years. Therefore, the growing prevalence rate of autoimmune diseases is expected to increase R&D activities; in turn, the demand for transfer membranes is anticipated to upsurge. Eventually, these factors are expected to fuel the target market growth over the forecast period.
However, the availability of alternative methods for protein transfer with high efficiency and automation is anticipated to hamper the market growth.
Transfer Membrane Market Trends
Western Blotting Segment Expected to have Lucrative Growth Over the Forecast Period
Western blotting is a widely known and used test in cell and molecular biology. The test helps to detect the specific type of protein from the complex mixture of proteins that are extracted from the cell. This test has gained attraction in the market due to its specificity, low cost, and ease of use. Western blot test has a wide range of applications in medical diagnostics, such as the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), FIV (Feline Immunodeficiency Virus), HBV (Hepatitis B Virus) infection, and Lyme Disease, among others. Generally, this test is used as a confirmatory test for the above-mentioned diseases after the ELISA test is done with a positive result. For instance, in July 2021, for Lyme Disease, the US FDA suggested that the two-tier protocol use an ELISA test initially and then the specific western blot test for the confirmation of diagnosis if the results of the ELISA are positive. Hence, these factors will have a positive impact on the target market over the studied period.
Previously, western blotting was commonly done to confirm the HIV diagnosis. However, the Centre for Disease Control and Prevention (CDC) in the year has recommended discontinuing the Western blot test for HIV as there are novel techniques that came up in the market for HIV detection. Furthermore, studies have suggested that western blot is a priority test for the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy) and FIV (Feline Immunodeficiency Virus). Therefore, due to the above-mentioned factors, it is projected that the target segment will witness a high CAGR during the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
The North American region is anticipated to have a significant market share owing to a large number of R&D activities, huge investments in developing new drugs, and support from public and private organizations for research. Moreover, the growing prevalence of chronic diseases coupled with rising targeted diseases in the region is anticipated to boost regional growth. According to the American Cancer Society's 2022 annual report, it was observed that there were an estimated 1.9 million new cancer cases in the United States during 2022. Hence, such a factor will positively influence the target market growth in the forecast period.
Research and development budgets of pharmaceutical companies have also increased in the last few years, owing to the increasing focus on regulating markets, complex molecules, and therapy segments. In the United States, pharmaceutical companies spend more money, time, and energy on R&D than others. According to the 2021 PhRMA Annual Membership Survey, the total amount spent on research and development by its member companies reached USD 91 billion. Therefore, the rise in R&D activities in the region is expected to increase the demand for transfer membranes, which, in turn, is expected to aid the growth of the market studied in the region over the forecast period.
Transfer Membrane Industry Overview
The transfer membrane market is moderately competitive, with the presence of a few key players operating in the market, including Merck KGaA, PerkinElmer Inc., Pall Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Abcam PLC, General Electric, Santa Cruz Biotechnology Inc., Axiva Sichem Biotech, Macherey-Nagel, GE Healthcare, and ATTO Corporation.
Transfer Membrane Market Leaders
Merck KGaA
PerkinElmer, Inc.
Pall Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc.
*Disclaimer: Major Players sorted in no particular order
Transfer Membrane Market News
- Apr 2022: Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its AvivaBlot product line of ECL reagents for western blot application. This new portfolio supports picogram to low femtogram detection of proteins via enhanced and stabilized chemiluminescent detection.
- Dec 2021: Merck, through its Life Science business unit, secured a EUR 121 million US federal government contract to build a lateral flow membrane production facility in Sheboygan, Wisconsin, United States. The agreement aims to increase the local production and supply of critical products for pandemic preparedness in the country.
- Jul 2021: Cytiva and Pall Corporation invested USD 1.5 billion over two years to meet the growing demand for biotechnology solutions. Part of the investments will increase the production and delivery capabilities for membrane and filter goods products.
Transfer Membrane Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of Targeted Diseases and Introduction of New Treatment Technologies
4.2.2 Growing Public and Private Investments in Research
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.3.2 Availability of Alternative Technologies
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type
5.1.1 Nitrocellulose Transfer Membrane
5.1.2 Polyvinylidene Fluoride (PVDF) Transfer Membrane
5.1.3 Nylon Transfer Membrane
5.2 By Transfer Method
5.2.1 Dry Electrotransfer
5.2.2 Semi-Dry Electrotransfer
5.2.3 Tank Elelctrotransfer
5.3 By Application
5.3.1 Western Blotting
5.3.2 Southern Blotting
5.3.3 Northern Blotting
5.3.4 Others
5.4 By End User
5.4.1 Academic Research Institutions
5.4.2 Pharmacuitical and Biotechnological Companies
5.4.3 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Merck KGaA
6.1.2 PerkinElmer, Inc.
6.1.3 Pall Corporation
6.1.4 Thermo Fisher Scientific
6.1.5 Bio-Rad Laboratories, Inc.
6.1.6 Abcam plc
6.1.7 General Electric
6.1.8 Santa Cruz Biotechnology, Inc.
6.1.9 Axiva Sichem Biotech
6.1.10 ATTO Corporation
6.1.11 Macherey-Nagel
6.1.12 GE Healthcare
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Transfer Membrane Industry Segmentation
As per the scope, a transfer membrane is a microporous membrane that is used in the detection and analysis of proteins and nucleic acids. These are also used to transfer proteins from gel matrices. These transfer membranes are used in various blotting techniques such as northern, southern, western, and protein sequencing.
The Transfer Membrane Market is Segmented By Type (Nitrocellulose Transfer Membrane, Polyvinylidene Fluoride (PVDF) Transfer Membrane, and Nylon Transfer Membrane), Transfer Method (Dry Electrotransfer, Semi-Dry Electrotransfer, and Tank Electrotransfer), Application (Western Blotting, Southern Blotting, Northern Blotting, and Other Applications), End User (Academic Research Institutions, Pharmaceutical, and Biotechnological Companies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.
| By Type | |
| Nitrocellulose Transfer Membrane | |
| Polyvinylidene Fluoride (PVDF) Transfer Membrane | |
| Nylon Transfer Membrane |
| By Transfer Method | |
| Dry Electrotransfer | |
| Semi-Dry Electrotransfer | |
| Tank Elelctrotransfer |
| By Application | |
| Western Blotting | |
| Southern Blotting | |
| Northern Blotting | |
| Others |
| By End User | |
| Academic Research Institutions | |
| Pharmacuitical and Biotechnological Companies | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Transfer Membrane Market Research FAQs
What is the current Global Transfer Membrane Market size?
The Global Transfer Membrane Market is projected to register a CAGR of 1.5% during the forecast period (2024-2029)
Who are the key players in Global Transfer Membrane Market?
Merck KGaA, PerkinElmer, Inc., Pall Corporation, Thermo Fisher Scientific and Bio-Rad Laboratories, Inc. are the major companies operating in the Global Transfer Membrane Market.
Which is the fastest growing region in Global Transfer Membrane Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Transfer Membrane Market?
In 2024, the North America accounts for the largest market share in Global Transfer Membrane Market.
What years does this Global Transfer Membrane Market cover?
The report covers the Global Transfer Membrane Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Transfer Membrane Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Transfer Membrane Industry Report
Statistics for the 2023 Transfer Membrane market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Transfer Membrane analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
